X

Use of cookies
We use our own and third-party cookies to improve our services and to show you advertisements related to your preferences through analysis of your browsing habits. If you continue to browse, it is considered that you accept their use. You can change your configuration or find more information here.

Participation in competitive projects

Financed projects

IGENOMIX has actively worked since its origins by applying research to reproductive health. This effort is now being supported by several financial agencies through the projects indicated below.

 

  • IVACE, PROGRAMA AYUDAS PLAN INTERNACIONALIZACIÓN. ITAPIN IT16 PLANES DE INTERNACIONALIZACIÓN PYME CV. REF. ITAPIN/2016/459. Plan Estratégico de internacionalización de la empresa IGENOMIX SL.
  • ICEX CONSOLIDA INFRAESTRUCTURAS, MED. AMBIENTE. 0201404462. ICON 01 IGENOMIX, S.L. Brasil 2014. IVIOMICS LABORATORIO DE MEDICINA GENETICA LTDA.
  • ICEX CONSOLIDA INFRAESTRUCTURAS, MED. AMBIENTE. 0201404463. ICON 01 IGENOMIX, S.L. UAE 2014. IGENOMIX FZ-LLC
  • MINECO. EQUIPA 2014 EQU-2014-1-0295. Acquisition of Next Generation Sequencing Platform
  • IVACE, 2014. IMEXPA/2014/24. New staff for RTD Department to develop NGS methods in ERA Diagnostic Test.
  • NIH. 2010-2015. NIH R01 HD21341. A program of research in population cytogenetics.
  • EUROSTAR. 2011-2014. CIIP-20112001. Non-invasive studies on endometrial dysfunction.
  • Spanish Ministry of Science and Innovation. 2008-2011. SAF2008-02048. Isolation and characterisation of endometrial somatic stem cells in endometriosis. Pathogenic and therapeutic implications.
  • Regional Valencian Ministry of Education. 2008-2011. PROMETEO/2008/163. Isolation and characterisation of the endometrial somatic stem cell population in endometriosis. Pathogenic and therapeutic implications.
  • Spanish Ministry of Health and Consumption. Instituto de Salud Carlos III. 2008-2011. RD06/0010/1006. The Cell Therapy Network.
  • Instituto de Salud Carlos III. 2008-2011. PI08-1134. Derivation of human embryonic cell lines from blastomeres by maintaining embryonic viability.
  • Instituto de Salud Carlos III. 2009-2010. RD09/0076/00063. RETICS – The Biobanks Network.
  • Spanish Ministry of Foreign Affairs. 2009. AECI. A/018463/08. Search, isolation and characterisation of adult myomata-forming adult stem cells.
  • Basque Country Government. 2008-2010. Etorgai. biomics – Personalised Medicine applied to clinical diagnoses.
  • The Gent per Gent Foundation. 2009-2012. Characterisation of neoplasia stem cells in endometrial cancer. Pathogenic, prognastic and therapeutic implications.
  • ANECOVA SA. 2004-2010. Development of an intrauterine device systemTM using the encapsulation technology for assisted in vivo culture of male and female gametes or preimplantatory embryos in mammalian species.
  • Spanish Ministry of Science and Technology. Dec.2004-Dec.2007. SAF2004-00204. Identification, characterisation and isolation of adult stem cells in the human endometrium; implications for the endometrium and endometrial cancer.
  • IMPIVA, 2012-2013. IMIDCB/2012/65. MonoCheck: R+D for optimal development  of a monogenic disease detection kit in the reproductive medicine area
  • IMPIVA, 2011. IMIDTF/2011/139. PHARMACOGENOMICS OF OVARIAN STIMULATION CYCLES. CLINICAL APPLICATION.
  • IMPIVA, 2011. INIDIV/2011/149. SELECTION OF A PROBIOTIC FOR VAGINAL APPLICATION (THE PROBIOVAG PROJECT).
  • MICINN, 2010. PTQ-10-02821. TORRES QUEVEDO.
  • IMPIVA, 2010-2011. IMIDTF/2010/129-IMIDTF/2011/140. DEVELOPMENT OF A DIAGNOSIS SYSTEM FOR PREMATURE OVARIAN FAILURE (POF).
  • IMPIVA, 2010. IMIDTF/2010/127. SFA (SPERM FERTILITY ARRAY). ASSESSMENT OF THE FERTILE POTENTIAL OF HUMAN SEMEN SAMPLES USING MICROARRAY TECHNOLOGY.
  • Regional Valencian Ministry of Industry, Generalitat Valenciana, 2009-2010. INIDIV/2009/086. GEN-VAL: THE VALENCIAN OPTION IN INDUSTRIAL GENOMICS.
  • IMPIVA, 2009. IMIDTF/2009/49. THE STUDY AND VALIDATION OF A NEW TECHNOLOGY TO ENHANCE THE PURITY AND QUANTITY OF FETAL DNA OBTAINED IN MATERNAL BLOOD TO BE USED IN PRENATAL DIAGNOSES.
  • IMPIVA, 2009. IMPCNG/2009/5. METABOLOMIC EMBRYONIC PROFILE AS A NON-INVASIVE CHROMOSOMAL DIAGNOSIS TOOL.